INTRODUCCIÓN: REVISIÓN CRITICA DEL PROBLEMA

CAPÍTULO VIII
197. Nivoit P, Wiernsperger N, Moulin P, Lagarde M, Renaudin C. Effect of glycated LDL on
microvascular tone in mice: a comparative study with LDL modified in vitro or isolated
from diabetic patients. Diabetologia. 2003 Nov;46(11):1550-8.
198. Younis N, Sharma R, Soran H, Charlton-Menys V, Elseweidy M, Durrington PN.Glycation as
an atherogenic modification of LDL. Curr Opin Lipidol. 2008 Aug;19(4):378-84.
199. Yegin A, Ozben T, Yegin H. Glycation of lipoproteins and accelerated atherosclerosis in noninsulin-dependent
diabetes mellitus. Int J Clin Lab Res. 1995;25(3):157-61.
200. Lyons TJ. Glycation and oxidation: a role in the pathogenesis of atherosclerosis. Am J
Cardiol. 1993 Feb 25;71(6):26B-31B.
201. Knott HM, Brown BE, Davies MJ, Dean RT.Glycation and glycoxidation of low-density
lipoproteins by glucose and low-molecular mass aldehydes. Formation of modified and
oxidized particles. Eur J Biochem. 2003 Sep;270(17):3572-82
202. Reddy GK. AGE-related cross-linking of collagen is associated with aortic wall matrix
stiffness in the pathogenesis of drug-induced diabetes in rats. Microvasc Res. 2004
Sep;68(2):132-42.
203. Reiser KM. Nonenzymatic glycation of collagen in aging and diabetes. Proc Soc Exp Biol
Med. 1991 Jan;196(1):17-29.
204. Li Y, Qi Y, Kim MS, Xu KZ, Huang TH, Rong X, Murray M, Yamahara J. Increased renal
collagen cross-linking and lipid accumulation in nephropathy of Zucker diabetic fatty rats.
Diabetes Metab Res Rev. 2008 Sep;24(6):498-506.
205. Hector EE, Robins SP, Mercer DK, Brittenden J, Wainwright CL. Quantitative measurement
of mature collagen cross-links in human carotid artery plaques. Atherosclerosis. 2010
Aug;211(2):471-4.
206. Sugimoto K, Yasujima M, Yagihashi S. Role of advanced glycation end products in diabetic
neuropathy. Curr Pharm Des. 2008;14(10):953-61. Review.
207. Thornalley PJ.Glycation in diabetic neuropathy: characteristics, consequences, causes, and
therapeutic options. Int Rev Neurobiol. 2002;50:37-57.
208. Dickinson PJ, Carrington AL, Frost GS, Boulton AJ. Neurovascular disease, antioxidants and
glycation in diabetes. Diabetes Metab Res Rev. 2002 Jul-Aug;18(4):260-72.
209. Li YM, Dickson DW. Enhanced binding of advanced glycation endproducts (AGE) by the
ApoE4 isoform links the mechanism of plaque deposition in Alzheimer's disease.
Neurosci Lett. 1997 May 2;226(3):155-8.
210. Tabaton M, Perry G, Smith M, Vitek M, Angelini G, Dapino D, Garibaldi S, Zaccheo D, Odetti
P. Is amyloid beta-protein glycated in Alzheimer's disease? Neuroreport. 1997 Mar
3;8(4):907-9.
211. Kumar PA, Kumar MS, Reddy GB. Effect of glycation on alpha-crystallin structure and
chaperone-like function. Biochem J. 2007 Dec 1;408(2):251-8.
212. Hashim Z, Zarina S. Advanced glycation end products in diabetic and non-diabetic human
subjects suffering from cataract. Age (Dordr). 2011 Sep;33(3):377-84.
213. Blasiak J, Arabski M, Krupa R, Wozniak K, Zadrozny M, Kasznicki J, Zurawska M,
Drzewoski J. DNA damage and repair in type 2 diabetes mellitus. Mutat Res. 2004 Oct
4;554(1-2):297-304.
214. Cervantes-Laurean D, Jacobson EL, Jacobson MK.Glycation and glycoxidation of histones
by ADP-ribose. J Biol Chem. 1996 May 3;271(18):10461-9.
215. Tamae D, Lim P, Wuenschell GE, Termini J. Mutagenesis and repair induced by the DNA
advanced glycation end product N2-1-(carboxyethyl)-2'-deoxyguanosine in human cells.
Biochemistry. 2011 Mar 29;50(12):2321-9. Epub 2011 Feb 28.
216. Baliga V, Sapsford R Review article: Diabetes mellitus and heart failure--an overview of
epidemiology and management. Diab Vasc Dis Res. 2009 Jul;6(3):164-71. Review.
236